Microvascular Leakage as Therapeutic Target for Ischemia and Reperfusion Injury

Cells. 2023 May 9;12(10):1345. doi: 10.3390/cells12101345.

Abstract

Reperfusion injury is a very common complication of various indicated therapies such as the re-opening of vessels in the myocardium or brain as well as reflow in hemodynamic shutdown (cardiac arrest, severe trauma, aortic cross-clamping). The treatment and prevention of reperfusion injury has therefore been a topic of immense interest in terms of mechanistic understanding, the exploration of interventions in animal models and in the clinical setting in major prospective studies. While a wealth of encouraging results has been obtained in the lab, the translation into clinical success has met with mixed outcomes at best. Considering the still very high medical need, progress continues to be urgently needed. Multi-target approaches rationally linking interference with pathophysiological pathways as well as a renewed focus on aspects of microvascular dysfunction, especially on the role of microvascular leakage, are likely to provide new insights.

Keywords: capillary leak; clinical outcome; edema; organ protection; reperfusion injury.

Publication types

  • Review
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Ischemia
  • Models, Animal
  • Myocardium
  • Prospective Studies
  • Reperfusion Injury* / drug therapy

Grants and funding

The results in this publication are thematically linked but not directly related to specific activities of the project COVend, which has received funding from Horizon Europe research and innovation programs under grant agreement No 101045956 (COVend).